This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

£200 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
4 - 6 June, 2024
Excel London Platinum Suite

Alessandra Villa, PhD
Director Lead Generation at Molecular Partners AG


Alessandra Villa is leading the Lead-Generation group at Molecular Partners AG, with a focus on the generation of Radio-DARPin Therapeutics and multispecific DARPins. Alessandra is an Industrial Biotechnologist by training and obtained her PhD at ETH Zurich where she focused on antibody-based therapeutics in the group of Prof Dario Neri. After postdoctoral training on the characterization of patient-derived cancer stem cells, she joined Philochem AG as group leader on engineering and development of targeted cytokines for cancer therapy. In 2021, she joined Molecular Partners to explore the therapeutic potential of small repeat protein ligands (DARPins).

Agenda Sessions

  • Next-Generation DARPin-based Protein Therapeutics